
Anne L. Holleran
Examiner (ID: 1384, Phone: (571)272-0833 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1643, 1642 |
| Total Applications | 775 |
| Issued Applications | 297 |
| Pending Applications | 125 |
| Abandoned Applications | 356 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6372690
[patent_doc_number] => 20100080799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'WSTF REGULATES THE DNA DAMAGE RESPONSE OF H2A.X VIA NOVEL TYROSINE KINASE ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/561573
[patent_app_country] => US
[patent_app_date] => 2009-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 25423
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20100080799.pdf
[firstpage_image] =>[orig_patent_app_number] => 12561573
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/561573 | WSTF REGULATES THE DNA DAMAGE RESPONSE OF H2A.X VIA NOVEL TYROSINE KINASE ACTIVITY | Sep 16, 2009 | Abandoned |
Array
(
[id] => 6355237
[patent_doc_number] => 20100022447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'COMPOSITION FOR TREATING CANCER AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/557507
[patent_app_country] => US
[patent_app_date] => 2009-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5813
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20100022447.pdf
[firstpage_image] =>[orig_patent_app_number] => 12557507
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/557507 | Composition for treating cancer and use thereof | Sep 9, 2009 | Issued |
Array
(
[id] => 6187816
[patent_doc_number] => 20110171216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'MONOCLONAL ANTIBODIES SPECIFIC FOR PANCREATIC NEOPLASIA CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/062942
[patent_app_country] => US
[patent_app_date] => 2009-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 24438
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171216.pdf
[firstpage_image] =>[orig_patent_app_number] => 13062942
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/062942 | MONOCLONAL ANTIBODIES SPECIFIC FOR PANCREATIC NEOPLASIA CELLS | Sep 8, 2009 | Abandoned |
Array
(
[id] => 10018585
[patent_doc_number] => 09061054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-23
[patent_title] => 'ErbB-2 receptor targeting peptide'
[patent_app_type] => utility
[patent_app_number] => 12/555375
[patent_app_country] => US
[patent_app_date] => 2009-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21888
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12555375
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/555375 | ErbB-2 receptor targeting peptide | Sep 7, 2009 | Issued |
Array
(
[id] => 9009195
[patent_doc_number] => 08524491
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-03
[patent_title] => 'Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated'
[patent_app_type] => utility
[patent_app_number] => 12/554279
[patent_app_country] => US
[patent_app_date] => 2009-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13296
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12554279
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/554279 | Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated | Sep 3, 2009 | Issued |
Array
(
[id] => 6489051
[patent_doc_number] => 20100009439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'ANTI-IGF-I RECEPTOR ANTIBODIES, DNAs, VECTORS, HOST CELLS AND GENETIC CONSTRUCTS'
[patent_app_type] => utility
[patent_app_number] => 12/547543
[patent_app_country] => US
[patent_app_date] => 2009-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 17363
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20100009439.pdf
[firstpage_image] =>[orig_patent_app_number] => 12547543
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/547543 | Anti-IGF-I receptor antibodies, DNAs, vectors, host cells and genetic constructs | Aug 25, 2009 | Issued |
Array
(
[id] => 7566938
[patent_doc_number] => 20110287001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'METHOD OF TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 13/063307
[patent_app_country] => US
[patent_app_date] => 2009-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 10127
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20110287001.pdf
[firstpage_image] =>[orig_patent_app_number] => 13063307
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/063307 | METHOD OF TREATMENT | Aug 4, 2009 | Abandoned |
Array
(
[id] => 9238947
[patent_doc_number] => 08603738
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-10
[patent_title] => 'Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors'
[patent_app_type] => utility
[patent_app_number] => 12/462324
[patent_app_country] => US
[patent_app_date] => 2009-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7578
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12462324
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/462324 | Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors | Jul 30, 2009 | Issued |
Array
(
[id] => 8397940
[patent_doc_number] => 08268319
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-18
[patent_title] => 'Immunoconjugates with an intracellularly-cleavable linkage'
[patent_app_type] => utility
[patent_app_number] => 12/512526
[patent_app_country] => US
[patent_app_date] => 2009-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11263
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12512526
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/512526 | Immunoconjugates with an intracellularly-cleavable linkage | Jul 29, 2009 | Issued |
Array
(
[id] => 6348645
[patent_doc_number] => 20100021472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'METHODS FOR DIAGNOSING AND TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/510053
[patent_app_country] => US
[patent_app_date] => 2009-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 23187
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021472.pdf
[firstpage_image] =>[orig_patent_app_number] => 12510053
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/510053 | METHODS FOR DIAGNOSING AND TREATING CANCER | Jul 26, 2009 | Abandoned |
Array
(
[id] => 6374714
[patent_doc_number] => 20100081172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'N-Glycans and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/507047
[patent_app_country] => US
[patent_app_date] => 2009-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 30146
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20100081172.pdf
[firstpage_image] =>[orig_patent_app_number] => 12507047
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/507047 | N-Glycans and Uses Thereof | Jul 20, 2009 | Abandoned |
Array
(
[id] => 5484932
[patent_doc_number] => 20090274697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'Monoclonal Antibodies That Specifically Block Biological Activity Of A Tumor Antigen'
[patent_app_type] => utility
[patent_app_number] => 12/500144
[patent_app_country] => US
[patent_app_date] => 2009-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18967
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20090274697.pdf
[firstpage_image] =>[orig_patent_app_number] => 12500144
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/500144 | Monoclonal antibodies that specifically block biological activity of a tumor antigen | Jul 8, 2009 | Issued |
Array
(
[id] => 5464395
[patent_doc_number] => 20090324595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'CANCER PROGNOSTIC DIAGNOSTIC AND TREATMENT METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/488296
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 29812
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20090324595.pdf
[firstpage_image] =>[orig_patent_app_number] => 12488296
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/488296 | CANCER PROGNOSTIC DIAGNOSTIC AND TREATMENT METHODS | Jun 18, 2009 | Abandoned |
Array
(
[id] => 5373701
[patent_doc_number] => 20090311262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Method for Diagnosing Cancers Expressing the HER2 Receptor or its Truncated Variants'
[patent_app_type] => utility
[patent_app_number] => 12/479035
[patent_app_country] => US
[patent_app_date] => 2009-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10529
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20090311262.pdf
[firstpage_image] =>[orig_patent_app_number] => 12479035
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/479035 | Method for diagnosing cancers expressing the HER2 receptor or its truncated variants | Jun 4, 2009 | Issued |
Array
(
[id] => 6588870
[patent_doc_number] => 20100062000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'Rhamm, a Co-Receptor and Its Interactions with Other Receptors in Cancer Cell Motility and the Identification of Cancer Prognitor Cell Populations'
[patent_app_type] => utility
[patent_app_number] => 12/470453
[patent_app_country] => US
[patent_app_date] => 2009-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 32919
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20100062000.pdf
[firstpage_image] =>[orig_patent_app_number] => 12470453
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/470453 | Rhamm, a Co-Receptor and Its Interactions with Other Receptors in Cancer Cell Motility and the Identification of Cancer Prognitor Cell Populations | May 20, 2009 | Abandoned |
Array
(
[id] => 6346657
[patent_doc_number] => 20100330554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'DIAGNOSTIC KIT FOR SOLID CANCER AND MEDICAMENT FOR SOLID CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/467964
[patent_app_country] => US
[patent_app_date] => 2009-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 11169
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0330/20100330554.pdf
[firstpage_image] =>[orig_patent_app_number] => 12467964
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/467964 | DIAGNOSTIC KIT FOR SOLID CANCER AND MEDICAMENT FOR SOLID CANCER THERAPY | May 17, 2009 | Abandoned |
Array
(
[id] => 5303427
[patent_doc_number] => 20090298079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'HIGH AFFINITY BINDING SITE OF HGFR AND METHODS FOR IDENTIFICATION OF ANTAGONISTS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/465307
[patent_app_country] => US
[patent_app_date] => 2009-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9477
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298079.pdf
[firstpage_image] =>[orig_patent_app_number] => 12465307
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/465307 | High affinity binding site of HGFR and methods for identification of antagonists thereof | May 12, 2009 | Issued |
Array
(
[id] => 5969159
[patent_doc_number] => 20110150935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'TARGETED TREATMENT FOR PATIENTS WITH ESTROGEN RECEPTOR NEGATIVE AND PROGESTERONE RECEPTOR NEGATIVE BREAST CANCERS'
[patent_app_type] => utility
[patent_app_number] => 12/989233
[patent_app_country] => US
[patent_app_date] => 2009-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14623
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20110150935.pdf
[firstpage_image] =>[orig_patent_app_number] => 12989233
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/989233 | Targeted treatment for patients with estrogen receptor negative and progesterone receptor negative breast cancers | Apr 21, 2009 | Issued |
Array
(
[id] => 6195542
[patent_doc_number] => 20110027296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'ANTIBODIES FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/935838
[patent_app_country] => US
[patent_app_date] => 2009-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6586
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20110027296.pdf
[firstpage_image] =>[orig_patent_app_number] => 12935838
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/935838 | ANTIBODIES FOR TREATING CANCER | Apr 7, 2009 | Abandoned |
Array
(
[id] => 5385155
[patent_doc_number] => 20090226399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'MEDICAMENTS COMPRISING GENE RECOMBINANT ANTIBODY AGAINST GANGLIOSIDE GD3'
[patent_app_type] => utility
[patent_app_number] => 12/420142
[patent_app_country] => US
[patent_app_date] => 2009-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 26884
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226399.pdf
[firstpage_image] =>[orig_patent_app_number] => 12420142
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/420142 | MEDICAMENTS COMPRISING GENE RECOMBINANT ANTIBODY AGAINST GANGLIOSIDE GD3 | Apr 7, 2009 | Abandoned |